Paris, 5 July 2013 – ORÈGE, a French company and global player that designs, develops and industrializes innovative technological solutions for the treatment of complex effluents and sludge, today celebrated its listing on NYSE Euronext's regulated market in Paris.
Set up in 2005 by its three founding partners, ORÈGE now has 43 employees. The company works in two complementary areas: treatment of complex industrial effluents, and conditioning, treatment and recovery of municipal and industrial sludge. ORÈGE has used its innovation platform to develop two breakthrough technologies, both protected by several patents: SOFHYS® is a technology for treating complex, toxic and/or non-biodegradable effluents, and SLG® is a technology for conditioning sludge.
These treatment solutions offer municipalities and industrial businesses a real alternative to conventional treatment technologies: they are designed to be both more cost-effective and to meet new regulatory and environmental requirements.
ORÈGE (ticker: OREGE) was listed through the admission to trading of 6,455,306 existing shares and 6,211,420 new shares issued under a Global Offering after the full exercise of the Extension option and before any exercise of the Over-allotment option . It followed the company's transfer from the Free Market. The Global Offering raised around €20.1 million.
The admission and issue price of ORÈGE shares was set at €3.24 per share. Market capitalisation stood at around €57.7 million on the day of listing.
“We are all the more delighted with ORÈGE's listing in that it is the first cleantech business outside renewable energies to list on our European market. This new step in the company's development will enable it to remain at the cutting edge in its field and pursue growth in the fast-growing market for treatment of complex effluents and sludge for industry and municipalities, where regulatory requirements are increasingly strict” said Marc Lefèvre, Head of European Business Development and Client Coverage, Listings Europe, at NYSE Euronext. “NYSE Euronext is committed to serving small and medium-sized companies at all times, to facilitate their access to the market, enhance their visibility and improve the tradability of their shares.”
Pascal Gendrot, Co-founder and CEO of ORÈGE, added: “Listing represents a major step ahead in our company's business development, and is clearly a springboard for structuring new strategic partnerships. Today ORÈGE is France's first and only 100% cleantech company to list in Paris, and I would like to thank all of our staff and partners for investing in this tremendous project. I would also like to thank EREN S.A. and its main shareholder Mr Pâris Mouratoglou for the trust they have shown by investing in our company as we make our market debut.”
Information:
NYSE Euronext
Caroline Tourrier: +33 (0)1 49 27 10 82
ORÈGE
Agence Symorg
Jean-Christophe Labastugue: + 33 (0)6 03 45 11 37